Please assess the completion status of the following clinical trial:

Trial Title: Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Status post placement of durable ventricular assist device with stable clinical status for \>30days~* Hemoglobin \>6 g/dL AND \<13 g/dL (men) or \<12 g/dL (women) within last 90 days~* Serum ferritin \<100 ng/mL OR Serum ferritin 100-299 ng/mL with transferrin saturation \<20% within last 90 days~* Able and willing to provide written informed consent~Exclusion Criteria:~* Known hypersensitivity to Ferumoxytol injection or other intravenous iron preparation~* History of anaphylaxis~* Treatment with erythropoiesis stimulating agent or intravenous iron in last 3 months~* Renal failure on hemodialysis~* Respiratory failure on mechanical ventilation~* Disabling Stroke~* Ventricular assist device thrombosis~* Evidence of active gastrointestinal bleeding or other active blood loss~* Hospitalization \<30 days~* Pregnant or breastfeeding women

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 110 Years
- Healthy Volunteers: f

Study Arms:
- Ferumoxytol injection treatment (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).